Health Report - Separate stories podcast

Could semaglutide cut cardiovascular disease risk as well as diabetes?

11.20.2023 - By ABC listenPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Health news this week ... includes COVID as the "eighth wave" is cresting.

And drugs much discussed all year are the GLP-1 agonists, such as Ozempic—which treat diabetes, and effective for weight loss. New studies have tested them to protect against cardiovascular disease

More episodes from Health Report - Separate stories podcast